Risk of surgery in patients with stricturing type of Crohn's disease at the initial diagnosis: a single center experience.
Biological therapy
Crohn disease
Intestine, small
Stricturing type
Surgery
Journal
Intestinal research
ISSN: 1598-9100
Titre abrégé: Intest Res
Pays: Korea (South)
ID NLM: 101572802
Informations de publication
Date de publication:
Jul 2019
Jul 2019
Historique:
received:
23
07
2018
accepted:
23
01
2019
pubmed:
21
2
2019
medline:
21
2
2019
entrez:
21
2
2019
Statut:
ppublish
Résumé
It remains uncertain which patients with stricturing-type Crohn's disease (CD) require early small bowel surgery after the initial diagnosis. We aimed to clarify clinical characteristics associated with the intervention in such condition of CD. We retrospectively evaluated the clinical course of 53 patients with CD and small bowel strictures who were initially treated with medications after the initial diagnosis. We investigated possible associations between small bowel surgery and the following: clinical factors and radiologic findings at initial diagnosis and the types of medications administered during follow-up. Twenty-eight patients (53%) required small bowel resection during a median follow-up period of 5.0 years (range, 0.5-14.3 years). The cumulative incidence rates of small bowel surgery at 2, 5, and 10 years were 26.4%, 41.0%, and 63.2%, respectively. Univariate analysis indicated that obstructive symptoms (P=0.036), long-segment stricture (P<0.0001), and prestenotic dilation (P<0.0001) on radiography were associated with small bowel surgery, and immunomodulatory (P=0.037) and biological therapy (P=0.008) were significant factors during follow-up. Multivariate analysis revealed that long-segment stricture (hazard ratio [HR], 4.25; 95% confidence interval [CI], 1.78-10.53; P=0.001) and prestenotic dilation (HR, 3.41; 95% CI, 1.24-9.62; P=0.018) on radiography showed a positive correlation with small bowel surgery, and biological therapy (HR, 0.40; 95% CI, 0.15-0.99; P=0.048) showed a negative correlation. CD patients with long-segment stricture and prestenotic dilation on radiography seem to be at a higher risk of needing small bowel surgery. For such patients, early surgical intervention might be appropriate, even at initial diagnosis.
Sections du résumé
BACKGROUND/AIMS
OBJECTIVE
It remains uncertain which patients with stricturing-type Crohn's disease (CD) require early small bowel surgery after the initial diagnosis. We aimed to clarify clinical characteristics associated with the intervention in such condition of CD.
METHODS
METHODS
We retrospectively evaluated the clinical course of 53 patients with CD and small bowel strictures who were initially treated with medications after the initial diagnosis. We investigated possible associations between small bowel surgery and the following: clinical factors and radiologic findings at initial diagnosis and the types of medications administered during follow-up.
RESULTS
RESULTS
Twenty-eight patients (53%) required small bowel resection during a median follow-up period of 5.0 years (range, 0.5-14.3 years). The cumulative incidence rates of small bowel surgery at 2, 5, and 10 years were 26.4%, 41.0%, and 63.2%, respectively. Univariate analysis indicated that obstructive symptoms (P=0.036), long-segment stricture (P<0.0001), and prestenotic dilation (P<0.0001) on radiography were associated with small bowel surgery, and immunomodulatory (P=0.037) and biological therapy (P=0.008) were significant factors during follow-up. Multivariate analysis revealed that long-segment stricture (hazard ratio [HR], 4.25; 95% confidence interval [CI], 1.78-10.53; P=0.001) and prestenotic dilation (HR, 3.41; 95% CI, 1.24-9.62; P=0.018) on radiography showed a positive correlation with small bowel surgery, and biological therapy (HR, 0.40; 95% CI, 0.15-0.99; P=0.048) showed a negative correlation.
CONCLUSIONS
CONCLUSIONS
CD patients with long-segment stricture and prestenotic dilation on radiography seem to be at a higher risk of needing small bowel surgery. For such patients, early surgical intervention might be appropriate, even at initial diagnosis.
Identifiants
pubmed: 30781932
pii: ir.2018.00107
doi: 10.5217/ir.2018.00107
pmc: PMC6667375
doi:
Types de publication
Journal Article
Langues
eng
Pagination
357-364Références
Dis Colon Rectum. 2000 Oct;43(10 Suppl):S85-93
pubmed: 11052483
Gut. 2001 Dec;49(6):777-82
pubmed: 11709511
Lancet. 2002 May 4;359(9317):1541-9
pubmed: 12047962
Gastroenterology. 1976 Mar;70(3):439-44
pubmed: 1248701
Surgery. 2004 Oct;136(4):854-60
pubmed: 15467672
Gastroenterology. 2006 Feb;130(2):323-33; quiz 591
pubmed: 16472588
Am J Gastroenterol. 2006 May;101(5):1030-8
pubmed: 16606351
Gut. 2006 Jun;55(6):749-53
pubmed: 16698746
Dis Colon Rectum. 2008 Jun;51(6):916-23
pubmed: 18322754
Surg Today. 2008;38(8):700-4
pubmed: 18668312
Gut. 2009 Apr;58(4):492-500
pubmed: 18832518
Gastroenterology. 2008 Nov;135(5):1493-9
pubmed: 18848553
Aliment Pharmacol Ther. 2009 Feb 1;29(3):279-85
pubmed: 19035967
Acta Gastroenterol Belg. 2008 Jul-Sep;71(3):303-7
pubmed: 19198576
Inflamm Bowel Dis. 2010 Jul;16(7):1187-94
pubmed: 19902541
N Engl J Med. 2010 Apr 15;362(15):1383-95
pubmed: 20393175
Dig Endosc. 2010 Jul;22(3):200-4
pubmed: 20642609
Dig Dis Sci. 2011 Nov;56(11):3247-53
pubmed: 21567189
Am J Gastroenterol. 2012 Apr;107(4):579-88
pubmed: 22233693
Lancet. 2012 Nov 3;380(9853):1590-605
pubmed: 22914295
Dig Liver Dis. 2013 Mar;45(3):258-62
pubmed: 23195667
Gut. 2013 Nov;62(11):1556-65
pubmed: 23263249
Dig Liver Dis. 2013 Jun;45(6):464-8
pubmed: 23465684
J Gastroenterol Hepatol. 2013 Aug;28(8):1300-5
pubmed: 23488881
Gut. 2013 Jul;62(7):1072-84
pubmed: 23626373
Gastroenterology. 2013 Oct;145(4):758-65.e2; quiz e14-5
pubmed: 23644079
Gut. 2014 Oct;63(10):1607-16
pubmed: 24056767
Am J Gastroenterol. 2014 Jan;109(1):23-34; quiz 35
pubmed: 24322839
Clin Gastroenterol Hepatol. 2014 Sep;12(9):1494-502.e1
pubmed: 24440221
Gastroenterology. 2014 Aug;147(2):334-342.e3
pubmed: 24732015
World J Gastroenterol. 2014 Sep 7;20(33):11808-14
pubmed: 25206286
Lancet. 2015 Apr 11;385(9976):1406-17
pubmed: 25542620
Aliment Pharmacol Ther. 2015 Oct;42(8):990-9
pubmed: 26271196
Gastroenterology. 2016 Jun;150(7):1568-1578
pubmed: 26946343
Inflamm Bowel Dis. 2016 May;22(5):1246-61
pubmed: 27070909
J Crohns Colitis. 2017 Jan;11(1):3-25
pubmed: 27660341
J Gastroenterol. 2018 Mar;53(3):305-353
pubmed: 29429045